What is NDC 0270-0149?

0270-0149 is the product NDC for Cystografin (diatrizoate meglumine), Diatrizoate meglumine 300 mg/mL injection, solution, listed with the FDA by BRACCO DIAGNOSTICS INC. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Cystografin (Diatrizoate meglumine).

BRACCO DIAGNOSTICS INC, NDC labeler code 0270. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cystografin?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cystografin NDC 0270-0149 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0270-0149Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00270-0149Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0270-0149-57	0027001495700270014957	10 BOTTLE in 1 PACKAGE (0270-0149-57) / 300 mL in 1 BOTTLEMarketed from Nov 3, 1970
0270-0149-60	0027001496000270014960	10 BOTTLE in 1 PACKAGE (0270-0149-60) / 100 mL in 1 BOTTLEMarketed from Nov 3, 1970

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cystografin
Generic name (nonproprietary): diatrizoate meglumine
Active ingredients: Diatrizoate meglumine — 300 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: BRACCO DIAGNOSTICS INCNDC labeler code 0270
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 010040
Marketing start: Nov 3, 1970
Listing expires: Dec 31, 2027
Other FDA classes: X-Ray Contrast Activity (Mechanism)
Identifiers: Product ID 0270-0149_6b067ea9-50b4-0ec7-1f1c-e07b00faced4SPL ID 6b067ea9-50b4-0ec7-1f1c-e07b00faced4SPL set ID 7496d736-9f7d-4136-ad5d-b24c7803c21bUNII 3X9MR4N98U
Pharmacologic class: Radiographic Contrast Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400270014957 followed by a unit qualifier and the quantity

Package 00270-0149-57. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 23, 2025.

Indications (excerpt from the label)

INDICATION Cystografin is indicated for retrograde cystourethrography.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0270-0149

What is NDC 0270-0149?: 0270-0149 is the product NDC for Cystografin (diatrizoate meglumine), Diatrizoate meglumine 300 mg/mL injection, solution, listed with the FDA by BRACCO DIAGNOSTICS INC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cystografin (Diatrizoate meglumine).
What is the active ingredient?: Diatrizoate meglumine.
Who is the labeler?: BRACCO DIAGNOSTICS INC, NDC labeler code 0270. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cystografin?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 010040

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 010040
Product	Strength	Form · route	Labeler	Product NDC
Cystografin Dilutediatrizoate meglumine	Diatrizoate meglumine 180 mg/mL	Injection, SolutionIntravesical	BRACCO DIAGNOSTICS INC	0270-1410

Cystografin (Diatrizoate meglumine) NDC 0270-0149